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T1 – Myokines
T1:PO.034
Change of circulating irisin concentrations in morbidly obese 
patients after roux-en-y gastric bypass
Lee Y.J.1, Hur Y.2, Choi J.1
1Department of Family Medicine, Obesity center, University Hospital and 
Faculty of Medicine in Inha University in Incheon, Republic of Korea,  
2Department of Surgery, Obesity center, University Hospital and Faculty of 
Medicine in Inha University in Incheon, Republic of Korea
Background: Irisin, a humoral factor secreted from muscle (myokine), 
has been known to stimulate the program of brown fat development in 
adipose tissue (“browning”). Recent animal studies suggested that irisin 
has possibility to enhance energy expenditure in obese patients. However, 
we have limited clinical data to understand biology of irisin in human, 
especially in morbidly obese patients taken bariatric surgery.
Methods: !is is a pilot, single center, longitudinal, observational study. 
We recruited twelve morbidly obese subjects (25–56 years, 29.6~45.9 kg/
m2 of BMI) who underwent Roux-en-Y gastric bypass surgery (RYGBP) 
and visited the obesity center postoperatively. Fasting serum samples for 
measuring irisin were collected preoperatively, and one and nine months 
a"er RYGBP. We analyzed the association between irisin concentrations 
and clinical characteristics.
Results: Serum irisin concentrations, 1.0115 ± 0.2282 μg/ml ranging from 
0.7347 to 1.4928 pre-operatively, altered bidirectionally on one month af-
ter RYGBP. Five out of twelve subjects showed increased irisin levels from 
0.9028 ± 0.7387 (range, 0.8393 – 0.9865) μg/ml to 1.6975 ± 0.6593 (range, 
1.0439 – 2.5102) μg/ml, while seven of them had decreased irisin levels 
from 1.0891 ± 0.2738 (range, 0.7347 – 1.4928) μg/ml to 0.8304 ± 0.1855 
(range, 0.5535 – 1.1560) μg/ml. Serum irisin concentrations on 9 months 
were 1.1108 ± 0.1515 μg/ml (range, 0.9158 – 1.3481), and eight had elevat-
ed irisin levels by 0.1827 ± 0.1400 μg/ml and four had non-elevated levels 
by - 0.0675 ± 0.0538 μg/ml compared with pre-operative values.
Conclusions: !e alteration of serum irisin level was associated with 
weight loss e%ect of Bariatric surgery.
T1 – Gut microbiota
T1:PO.035
In!uence of panax ginseng on obesity and gut microbiota in 
obese middle-aged korean women
Song M.1, Kim H.1, Choi H.2, Choi Y.3, Chin Y.3, Wang J.1
1Department of Rehabilitation Medicine of Korean Medicine, Dongguk 
University,  
2Department of Endocrinology, Dongguk University,  
3College of pharmacy, Dongguk University 
Gut microbiota is regarded as one of the major factors involved in control 
of body weight. !e anti-obesity e%ects of ginseng and its main constitu-
ents have been demonstrated, however, the e%ects on gut microbiota are 
still unknown. To investigate the e%ect of ginseng on gut microbiota, 10 
obese middle-aged Korean women took Panax ginseng extracts for eight 
weeks and assessment of body composition parameters, metabolic bio-
markers, and gut microbiota composition was performed using 16S rRNA 
gene-based pyrosequencing at baseline and at wk 8. Signi&cant changes 
were observed in body weight and BMI, however, slight changes were ob-
served in gut microbiota. We divided the subjects into two groups, the 
e%ective weight loss group (EWG) and the ine%ective weight loss group 
(IWG), depending on weight loss e%ect, in order to determine whether 
the anti-obesity e%ect was in'uenced by composition of gut microbiota, 
and the composition of gut microbiota was compared between the two 
groups. Before ginseng intake, signi&cant di%erences of gut microbiota 
were observed between both at phyla and genera and the gut microbiota 
of the EWG and IWG was segregated on a principal coordinate analysis 
plot. Results of this study indicate that ginseng exerted a weight loss ef-
fect and slight e%ects on gut microbiota in all subjects. In addition, its an-
ti-obesity e%ects di%ered depending on the composition of gut microbiota 
before ginseng intake.
Fig. 1. !e phylum compositions of fecal bacteria were compared before treatment 
in the EWG and IWG. !e relative contribution abundance of dominant phyla 
identi&ed from pyrosequencing data is shown. EWG, e%ective weight loss group; 
IWG, ine%ective weight loss group.
Fig. 2. Principal coordinate analysis (PCoA) plot. !e plot showed the clustering 
pattern between the EWG and IWG based on weighted pairwise Fast UniFrac 
analysis.Full line circles indicate grouping of the communities in the before 
ginseng intake and dotted line circles indicate that in the a"er ginseng intake.
T1:PO.036
High-fat diet-induced obesity rat model: A comparison 
between wistar and sprague-dawley rat
Marques C.1,2, Meireles M.1, Norberto S.1, Leite J.1, Freitas J.1,3, Pestana D.1,2, 
Faria A.1,4,5, Calhau C.1,2
1Departamento de Bioquímica, Faculdade de Medicina, Universidade do Porto, 
Porto, Portugal,  
2CINTESIS, Centro de Investigaçăo em Tecnologias e Sistemas de Informaçăo em 
Saúde, Porto, Portugal,  
3Universidade de Trás-os-Montes e Alto Douro, Vila Real, Portugal,  
4Faculdade de Cięncias da Nutriçăo e da Alimentaçăo, Universidade do Porto, 
Porto, Portugal,  
5Faculdade de Cięncias, Universidade do Porto, Porto, Portugal
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Introduction: In the past decades, obesity and associated metabolic com-
plications have reached epidemic proportions. For the study of these pa-
thologies, a number of animal models have been developed. However, a 
direct comparison between Wistar and SD Rat as models of high-fat (HF) 
diet-induced obesity has not been adequately evaluated so far. 
Methods: Wistar and SD rats were both assigned for two experimental 
groups for 17 weeks: standard (St) and high-fat (HF) diet groups. To assess 
some of the features of the metabolic syndrome, oral glucose tolerance 
tests, systolic blood pressure measurements and blood biochemical analy-
sis were performed throughout the study. !e gut microbiota composition 
of the animals from each group was evaluated at the end of the study by 
real-time PCR. 
Results: HF diet increased weight gain, body fat mass, mesenteric adipo-
cyte’s size, adiponectin and leptin plasma levels and decreased oral glu-
cose tolerance in both Wistar and SD rats. However, the majority of these 
e%ects were more pronounced or earlier detected in Wistar rats. !e gut 
microbiota of SD rats was less abundant in Bacteroides and Prevotella but 
richer in Bi&dobacterium and Lactobacillus comparatively to the gut mi-
crobiota of Wistar rats. Nevertheless, the modulation of the gut microbi-
ota by HF diet was similar in both strains, except for Clostridium leptum 
that was only reduced in Wistar rats fed with HF diet. 
Conclusion: Both Wistar and SD Rat can be used as models of HF diet-in-
duced obesity although the metabolic e%ects caused by HF diet seemed to 
be more pronounced in Wistar Rat. Di%erences in the gut microbial ecol-
ogy together with other mechanisms, such as increased gut permeability, 
may account for the worsened metabolic scenario observed in Wistar Rat.
Acknowledgement: !is work was supported by Fundaçăo para Cięncia e Tecnolo-
gia (PTDC/AGR-TEC/2227/2012; SFRH/BPD/75294/2010; SFRH/BD/78367/2011 
and SFRH/BD/93073/2013).
T1 – Gut hormones/incretins
T1:PO.037
The relationship between serum amylase and fasting plasma 
ghrelin, peptide yy3–36 in healthy men
Tak Y.J.1, Lee S.Y.2
1Department of Family Medicine, Pusan National University Hospital, Pusan 
National University Hospital, Busan, South Korea,  
2Obesity, Nutrition and Metabolism Clinic, Department of Family Medicine, 
Research Institute of Convergence of Biomedical Science and Technology, 
Pusan National University Yangsan Hospital, Yangsan, South Korea
Objective: Both appetite and carbohydrate metabolism are important in 
development of obesity. Recently serum amylase has been shown to be as-
sociated with obesity as well as metabolic disorder. Here, we investigated 
the relationship between total amylase, ghrelin and peptide YY (PYY) in 
healthy men.
Materials and Methods: In this cross-sectional study, twenty-one men 
were enrolled and all subjects had no symptoms and no any medical his-
tory or diseases. Serum total amylase, fasting serum levels of ghrelin and 
PYY3-36, anthropometry and caloric intake per day were measured. Par-
tial correlation coe>cients adjusting for age and linear regression analy-
sis were computed to examine association between serum amylase and 
ghrelin, PYY3-36.
Results: !e mean age, body mass index and waist circumference (WC) 
of subjects were 51.5 ± 10.9 years, 24.2 ± 1.7 kg/m2 and 87.0 ± 4.4 cm, re-
spectively. !e subjects had no signi&cant di%erence in serum amylase, 
ghrelin and PYY3-36 according to presence of obesity. Serum amylase 
showed signi&cant correlation with WC (r = -0.438, P = 0.054), ghrelin 
(r = 0.533, P = 0.015) and PYY3-36 (r = -0.511, P = 0.021) a"er adjust-
ing for age. PYY3-36 showed statistically negatively associated with se-
rum amylase in multivariate linear regression model including age, WC 
(β = -0.428, P = 0.045). In contrast, positive association between ghrelin 
and serum amylase became non-signi&cant in multivariate linear regres-
sion model including age, WC (β = 0.260, P = 0.146).
Conclusion: Serum amylase levels were related with ghrelin and PYY3-
36 in men. Amylase, ghrelin and PYY3-36 together may relate to obesity, 
although further research is required to &nd the mechanism behind these 
associations.
Fig. 1. Serum amylase (A) and Ghrelin levels (B) between obese and non-obese 
group. Statistical signi&cance test between groups was done by Mann-Whitney 
U-test
Fig. 2. Correlation between waist circumference and serum amylase (A), ghrelin 
(B), peptide YY3-36 (C)
T1:PO.038
Di"erentially nibbling endogenous cannabinoid cb1 and 
cb2 receptor subtypes in spontaneous and splice variants of 
ghrelin-induced feeding in rats
Chen C.1,2, Ting C.1
1Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, 
Taiwan,  
2Division of Gastroenterology, Department of Medicine, Taipei Veterans General 
Hospital, Taipei, Taiwan
Objective: Dysregulation of endocannabinoid system has been reported 
leading to the development of obesity and metabolic disorders. Endoge-
nous endocannabinoids act on two cannabinoid receptor subtypes, type 1 
(CB1) and type 2 (CB2), to exert their biological actions. However, com-
prehensive information regarding CB1 and CB2 receptors in modulating 
feeding behavior is important, but remains less understood.
Methods: We investigated the di%erential roles of CB1 and CB2 recep-
tors in spontaneous and centrally-administered splice variants of ghrelin, 
O-n-octanoylated ghrelin and des-Gln14-ghrelin, stimulation of food in-
take in conscious rats.
Results: Intraperitoneal (IP) injection of di%erent doses of selective CB2 
receptor antagonist, AM-630 (0.3, 1.0, and 3.0 mg/kg), enhanced cumu-
lative food intake during the &rst 12 hours with a dome-shaped dose-re-
sponse relationship in freely-fed rats, with the most e%ective dose of 1.0 
mg/kg. In contrast, the selective CB1 receptor antagonist, AM-251 (0.3, 
1.0, and 3.0 mg/kg, IP) dose-dependently suppressed the cumulative food 
intake in 16-h food-deprived rats. Centrally-administered O-n-octanoy-
lated ghrelin and des-Gln14-ghrelin-induced hyperphagic e%ects were 
counteracted dose-dependently by IP AM-251, but not AM-630.
Conclusions: We showed that endogenous CB2 receptor plays a role in 
inhibiting food intake in satiated state, whereas CB1 receptor promotes 
food intake in fasted condition. Central acyl ghrelin induces feeding is 
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